Total expenditure on pharmaceuticals as a share of total health care expenditures fell 0.976% to 15.3% in Spain in 2018, according to OECD.
Historically, total expenditure on pharmaceuticals as a share of total health care expenditures in Spain reached an all time high of 22.7% in 2002 and an all time low of 15.3% in 2015.
Spain has been ranked 14th within the group of 30 countries we follow in terms of total expenditure on pharmaceuticals as a share of total health care expenditures, 2 places above the position seen 10 years ago.
Total Expenditure on Pharmaceuticals (As % of Total Health Care Expenditures) | Unit | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
Algeria | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
Austria | % | 11.9% | 12.1% | 12.3% | 12.0% | 12.1% | ... | |||||||||||||||
Belgium | % | ... | ... | ... | ... | 14.2% | 14.0% | 14.4% | 14.3% | 14.2% | ... | |||||||||||
France | % | 14.0% | 14.0% | 13.6% | 13.4% | 13.2% | ... | |||||||||||||||
Germany | % | 14.0% | 14.3% | 14.3% | 14.4% | 14.2% | ... | |||||||||||||||
Ireland | % | 13.5% | 13.1% | 13.0% | 13.0% | 12.9% | ... | |||||||||||||||
Italy | % | 17.1% | 17.0% | 17.9% | 17.6% | 17.6% | ||||||||||||||||
Mauritania | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
Morocco | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
Portugal | % | ... | 15.6% | 15.4% | 15.5% | 15.4% | 15.0% | ... | ||||||||||||||
Slovenia | % | ... | ... | ... | 20.1% | 18.5% | 18.3% | 18.3% | 18.4% | ... | ||||||||||||
Spain | % | 16.3% | 15.6% | 15.3% | 15.9% | 15.5% | ... | |||||||||||||||
Switzerland | % | 11.8% | 11.6% | 11.7% | 11.9% | 12.0% | ... | |||||||||||||||
Tunisia | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |